Cat on a Hot Twin Proof? After Cougar, Puma Roars
Puma Biotechnology Inc.'s CEO Alan Auerbach first became widely known in 2009 for the sale of his previous firm, Cougar Biotechnology Inc., to Johnson & Johnson for $970 million, based largely on the strength of Cougar's lead compound, abiraterone.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter